Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Adherium Ltd. ( (AU:ADR) ).
Adherium Limited has issued 62,666,668 fully paid ordinary shares without disclosure under Part 6D.2 of the Corporations Act 2001. The company confirms compliance with relevant provisions of the Corporations Act and states that no excluded information needs to be disclosed. This announcement reflects Adherium’s ongoing efforts to enhance its financial position and operational capabilities, potentially impacting its market presence and stakeholder interests.
More about Adherium Ltd.
Adherium is a global leader in integrated digital health solutions, specializing in connected respiratory medical devices. Its Hailie® platform enables clinicians, healthcare providers, and patients to remotely monitor medication usage and adherence, facilitating reimbursement for patient management. The platform includes mobile and desktop apps, SDK and API integration tools, and a range of sensors for respiratory medications, providing healthcare providers with insights into medication use patterns.
Technical Sentiment Signal: Sell
Current Market Cap: A$8.39M
See more data about ADR stock on TipRanks’ Stock Analysis page.